Nováková, 2012 - Google Patents
UHPLC in modern bioanalysisNováková, 2012
- Document ID
- 6287408127153045358
- Author
- Nováková L
- Publication year
External Links
Snippet
The measurement of drug concentrations in biological matrices is an important aspect of the drug development process for those products containing new active substances, as well as for line extensions and generic products. Such data may be required to support new …
- 238000001195 ultra high performance liquid chromatography 0 title description 91
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/461—Flow patterns using more than one column with serial coupling of separation columns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/30—Control of physical parameters of the fluid carrier of temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- G01N30/94—Development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Segers et al. | Analytical techniques for metabolomic studies: A review | |
| Gika et al. | Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art | |
| Nováková | Challenges in the development of bioanalytical liquid chromatography–mass spectrometry method with emphasis on fast analysis | |
| Jemal | High‐throughput quantitative bioanalysis by LC/MS/MS | |
| Hopfgartner et al. | Quantitative high‐throughput analysis of drugs in biological matrices by mass spectrometry | |
| Bian et al. | On the potential of micro-flow LC-MS/MS in proteomics | |
| Ackermann et al. | Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery | |
| Daryanavard et al. | Molecularly imprinted polymer in microextraction by packed sorbent for the simultaneous determination of local anesthetics: lidocaine, ropivacaine, mepivacaine and bupivacaine in plasma and urine samples | |
| Ashri et al. | Sample treatment based on extraction techniques in biological matrices | |
| Nováková et al. | Hydrophilic interaction chromatography of polar and ionizable compounds by UHPLC | |
| Bakhtiar et al. | Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography–mass spectrometry | |
| Thomas et al. | On‐line desorption of dried blood spots coupled to hydrophilic interaction/reversed‐phase LC/MS/MS system for the simultaneous analysis of drugs and their polar metabolites | |
| Rainville et al. | Advances in liquid chromatography coupled to mass spectrometry for metabolic phenotyping | |
| Hsieh | HPLC-MS/MS in drug metabolism and pharmacokinetic screening | |
| EP1962097A1 (en) | Mass spectrometric quantitative detection of methyl malonic acid and succinic acid using hilic on a zwitterionic stationary phase | |
| Hsieh et al. | Simultaneous determination of nicotinic acid and its metabolites using hydrophilic interaction chromatography with tandem mass spectrometry | |
| Kohler et al. | Multi-target screening of biological samples using LC–MS/MS: focus on chromatographic innovations | |
| Shan et al. | Nano‐LC: An updated review | |
| Plumb et al. | Quantitative analysis of pharmaceuticals in biological fluids using high-performance liquid chromatography coupled to mass spectrometry: a review | |
| Van Eeckhaut et al. | Toward greener analytical techniques for the absolute quantification of peptides in pharmaceutical and biological samples | |
| Chen et al. | Technologies to improve the sensitivity of existing chromatographic methods used for bioanalytical studies | |
| Cassiano et al. | Direct bioanalytical sample injection with 2D LC–MS | |
| Thakur et al. | Bioanalytical strategies in drug discovery and development | |
| Ashri et al. | Microextraction by packed sorbent and liquid chromatography–tandem mass spectrometry as a tool for quantification of peptides in plasma samples: determination of sensory neuron‐specific receptors agonist BAM8‐22 and antagonist BAM22‐8 in plasma samples | |
| Kromidas | Optimization in HPLC: Concepts and strategies |